Experts discuss treatment strategies for one patient with recurrent HNSCC and one with locally advanced HNSCC.
This activity is intended for oncologists, pathologists, radiologists, surgeons, and other healthcare professionals who manage patients with head and neck cancer.
The goal of this activity is to discuss the emergence of immunotherapy in head and neck cancer along with treatment approaches with both curative and noncurative disease and clinical trials.
Approximate Time to Complete: 35 minutes
Course Available Beginning: Dec. 20, 2016
Developed through a partnership between SITC and Medscape.
Upon completion of this activity, participants will be able to:
- Have increased knowledge regarding the appropriate modalities for patients with head and neck cancer based on factors such as medical history, stage of disease, anatomic site of cancer, human papillomavirus status, and patient preferences
- Have increased knowledge regarding the clinical trial options for the treatment of head and neck cancer